IL112183A - The use of bracadicinin antagonists in the preparation of drugs for the treatment of viral diseases - Google Patents

The use of bracadicinin antagonists in the preparation of drugs for the treatment of viral diseases

Info

Publication number
IL112183A
IL112183A IL11218394A IL11218394A IL112183A IL 112183 A IL112183 A IL 112183A IL 11218394 A IL11218394 A IL 11218394A IL 11218394 A IL11218394 A IL 11218394A IL 112183 A IL112183 A IL 112183A
Authority
IL
Israel
Prior art keywords
aryl
substituted
hydrogen
alkyl
radical
Prior art date
Application number
IL11218394A
Other languages
English (en)
Hebrew (he)
Other versions
IL112183A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL112183A0 publication Critical patent/IL112183A0/xx
Publication of IL112183A publication Critical patent/IL112183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11218394A 1993-12-31 1994-12-29 The use of bracadicinin antagonists in the preparation of drugs for the treatment of viral diseases IL112183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (2)

Publication Number Publication Date
IL112183A0 IL112183A0 (en) 1995-03-15
IL112183A true IL112183A (en) 2001-01-11

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11218394A IL112183A (en) 1993-12-31 1994-12-29 The use of bracadicinin antagonists in the preparation of drugs for the treatment of viral diseases

Country Status (21)

Country Link
US (1) US5789383A (fr)
EP (1) EP0661058B1 (fr)
JP (1) JP3828593B2 (fr)
KR (1) KR100358822B1 (fr)
CN (1) CN1119171C (fr)
AT (1) ATE255417T1 (fr)
AU (1) AU696629B2 (fr)
BR (1) BR9405308A (fr)
CA (1) CA2138933C (fr)
DE (2) DE4345062A1 (fr)
DK (1) DK0661058T3 (fr)
ES (1) ES2211874T3 (fr)
FI (1) FI117320B (fr)
HU (1) HU226374B1 (fr)
IL (1) IL112183A (fr)
MY (1) MY112888A (fr)
NO (1) NO317660B1 (fr)
PT (1) PT661058E (fr)
RU (1) RU2228195C2 (fr)
UA (1) UA41326C2 (fr)
ZA (1) ZA9410381B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (fr) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions pharmaceutiques comprenant un antagoniste du récepteur 2 de la bradykinine pour la prévention ou le traitement de la mauvaise cicatrisation de plaies sur la peau
CN116731101A (zh) 2016-06-01 2023-09-12 雅斯娜 用于治疗多种疾病的n-己酸-l-酪氨酸-l-异亮氨酸-(6)-氨基己酰胺的衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
EP0586613A4 (en) * 1991-04-01 1994-08-24 Cortech Inc Bradykinin antagonists
ATE169823T1 (de) * 1991-04-19 1998-09-15 Scios Nova Inc Bradykinin typische peptide
EP0618810B1 (fr) * 1991-04-19 2001-07-04 Scios Nova Inc. Peptides antagonistes de bradykinine
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds

Also Published As

Publication number Publication date
NO945094L (no) 1995-07-03
NO945094D0 (no) 1994-12-30
DE59410340D1 (de) 2004-01-15
UA41326C2 (uk) 2001-09-17
RU2228195C2 (ru) 2004-05-10
JP3828593B2 (ja) 2006-10-04
ATE255417T1 (de) 2003-12-15
PT661058E (pt) 2004-04-30
FI950010A0 (fi) 1995-01-02
KR100358822B1 (ko) 2003-01-24
EP0661058B1 (fr) 2003-12-03
DE4345062A1 (de) 1995-07-13
FI950010A (fi) 1995-07-01
EP0661058A1 (fr) 1995-07-05
ZA9410381B (en) 1995-08-29
MY112888A (en) 2001-10-31
HU9403783D0 (en) 1995-02-28
ES2211874T3 (es) 2004-07-16
CN1119171C (zh) 2003-08-27
US5789383A (en) 1998-08-04
JPH07206703A (ja) 1995-08-08
AU8179194A (en) 1995-07-13
RU94045140A (ru) 1996-10-20
KR950016779A (ko) 1995-07-20
CA2138933A1 (fr) 1995-07-01
CA2138933C (fr) 2010-02-23
AU696629B2 (en) 1998-09-17
HUT71422A (en) 1995-11-28
IL112183A0 (en) 1995-03-15
CN1108138A (zh) 1995-09-13
DK0661058T3 (da) 2004-04-05
FI117320B (fi) 2006-09-15
HU226374B1 (en) 2008-10-28
BR9405308A (pt) 1995-09-19
NO317660B1 (no) 2004-11-29

Similar Documents

Publication Publication Date Title
KR100352541B1 (ko) 노나-및데카펩타이드와,이를포함하는후천성면역결핍증치료용약제학적조성물
KR20000069045A (ko) 헵타펩티드 옥시토신 동족체
HU221092B1 (en) Compounds with growth hormone releasing properties
US11154587B2 (en) Use of peptides to stimulate the immune system
KR0173976B1 (ko) 브라디키닌에 대하여 길항작용을 하는 펩타이드
CA2138933C (fr) Application d'antagonistes de la bradykinine a l'obtention de medicaments servant au traitement de maladies virales
KR20000076211A (ko) 택산과 조합된 돌라스태틴-15 유도체
AU677290B2 (en) Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis
US11021526B2 (en) DSG2-derived peptides
US20060276390A1 (en) Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
CA2393755C (fr) Procedes permettant de traiter et d'empecher des lesions des muqueuses
KR100273620B1 (ko) 레트로바이러스 감염의 억제방법
US6869925B1 (en) Inhibition of retrovirus infection
US6245736B1 (en) Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease
KR940010032B1 (ko) 고혈압 치료용 약제학적 조성물의 제조방법
WO1999051254A1 (fr) Peptides courts destines au traitement des maladies neurodegeneratives
EP0455133A2 (fr) Peptides ayant une activité antagoniste pour la bradykinine
EP0537291A1 (fr) Procede de traitement de la nausee et des vomissements lies au mal des transports a l'aide d'antagonistes de vasopressine
HU224715B1 (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
US20050101539A1 (en) Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
EP0303243A2 (fr) Emploi du facteur atrionatrimétique (ANF), fragments et analogues de celui-ci pour le traitement des troubles cardiaques
LT3375B (en) Peptides and pharmaceutical composition containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired